All Articles

A pivotal trial shows an Indian-made heart valve performs on par with US leaders, signaling a major disruption in the high-stakes MedTech market.

A luxury hotel in Ishigaki is using a high-tech light show to fight the off-season slump. Is it a brilliant strategy or a threat to a fragile paradise?

NTT DOCOMO is deploying Nokia's AI to manage its 5G network, aiming for Level 4 autonomy, reduced costs, and a new era of operational efficiency.

As Beijing unveils its 15th Five-Year Plan, a strategic pivot to tech self-reliance challenges global investors to look beyond the headlines.

As tourists return to Macao with new spending habits, The St. Regis bets on experiential luxury with a Guerlain-scented festive season. Is this the future?

Co-founder Robert Ortenzio wants to take Select Medical private. We dive into whether his offer is a fair price or an opportunistic play for control.

Align Technology's new jaw-correcting aligner promises teens a comfortable fix for overbites. But do the clinical results match the digital promise?

Kate McAfoose's dual Gold Stevie® wins aren't just personal honors; they signal a market shift towards automation that empowers people and solves real-world crises.

A Chinese biotech's novel bispecific, dual-payload ADCs just secured $60M. Here’s how this new class of therapy aims to outsmart resistant tumors.

As holiday costs rise, platforms like MoneyMutual offer fast cash to those with bad credit. But is this tech-driven access a lifeline or a costly trap?

A new drug from Ascentage Pharma not only shows impressive results in a rare cancer but reveals a novel 'fat-starving' mechanism, boosting its pipeline.

Fidelity's estimated ETF capital gains are out. Beyond the tax headache, these numbers reveal key insights into market performance and fund strategy.

A massive real estate transaction in the San Gabriel Valley reveals a new model for tackling the housing crisis, blending private capital with public good.

As data breaches soar, a top marketing mind from LifeLock joins AI startup PrivacyHawk. Can they redefine personal data protection for millions?

Evolve's acquisition of 1,000 properties from Casago signals a major industry shift toward specialized, tech-driven vacation rental management models.

Hall Chadwick's $207M IPO signals a renewed appetite for SPACs. For capital-hungry AI health tech firms, this could be a new path to the public market.

Sabio's revenue fell in a non-political year, but surging programmatic and international sales signal a strategic shift. Is it enough for a 2026 rebound?

A C$30M financing, led by Pan American Silver, accelerates Galleon Gold's West Cache project and signals a strategic shift in the Timmins gold camp.

Rocket Lab's record-setting 19th launch of 2025 will carry a JAXA tech-demo satellite, a mission highlighting market leadership and US-Japan space diplomacy.

Real estate firm Montium taps a cross-sector HR leader to scale its $1B portfolio. This isn't just an HR hire; it's a blueprint for growth.